Reduction of BDNF Levels and Biphasic Changes in Glutamate Release in the Prefrontal Cortex Correlate with Susceptibility to Chronic Stress-Induced Anhedonia

eNeuro. 2023 Nov 21;10(11):ENEURO.0406-23.2023. doi: 10.1523/ENEURO.0406-23.2023. Print 2023 Nov.

Abstract

Chronic stress has been considered to induce depressive symptoms, such as anhedonia, particularly in susceptible individuals. Synaptic plasticity in the prefrontal cortex (PFC) is closely associated with susceptibility or resilience to chronic stress-induced anhedonia. However, effects of chronic stress with different durations on the neurobiological mechanisms that underlie susceptibility to anhedonia remain unclear. The present study investigated effects of chronic mild stress (CMS) for 14, 21, and 35 d on anhedonia-like behavior and glutamate synapses in the PFC. We found that brain-derived neurotrophic factor (BDNF) levels in the PFC significantly decreased only in anhedonia-susceptible rats that were exposed to CMS for 14, 21, and 35 d. Additionally, 14 d of CMS increased prefrontal glutamate release, and 35 d of CMS decreased glutamate release, in addition to reducing synaptic proteins and spine density in the PFC. Moreover, we found that anhedonia-like behavior in a subset of rats spontaneously decreased, accompanied by the restoration of BDNF levels and glutamate release, on day 21 of CMS. Ketamine treatment restored the reduction of BDNF levels and biphasic changes in glutamate release that were induced by CMS. Our findings revealed a progressive reduction of synaptic plasticity and biphasic changes in glutamate release in the PFC during CMS. Reductions of BDNF levels may be key neurobiological markers of susceptibility to stress-induced anhedonia.

Keywords: BDNF; anhedonia susceptibility; chronic stress; glutamate release; ketamine; prefrontal cortex.

MeSH terms

  • Anhedonia*
  • Animals
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Glutamic Acid / metabolism
  • Prefrontal Cortex / metabolism
  • Rats
  • Rats, Wistar
  • Stress, Psychological / complications

Substances

  • Brain-Derived Neurotrophic Factor
  • Glutamic Acid